Cellier, C., Bouma, G., van Gils, T., Khater, S., Malamut, G., Crespo, L., Collin, P., Green, P. H. R., Crowe, S. E., Tsuji, W., Butz, E., Cerf-Bensussan, N., Macintyre, E., Parnes, J. R., Leon, F., Hermine, O., Mulder, C. J., & , (2019). safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. Lancet gastroenterology and hepatology, 4, 960–970. http://access.bl.uk/ark:/81055/vdc_100094622980.0x000003